Pharmaceutical shipments from India to the United States are poised for significant growth by 2025. This phenomenon is driven by a confluence of factors, including India's established reputation as a global manufacturing hub for affordable medicines and the increasing need for quality healthcare solutions in the USA. Nevertheless, navigating the co